PharmaShots | Incisive News in 3 Shots

Subscribe Now

Signed

Y-Biologics Signs a License Agreement with 3D Medicines for YBL-013 in the Territory of Greater China

Y-Biologics Signs a License Agreement with 3D Medicines for YBL-013 in the Territory of Greater China

January 5, 2021

AbbVie Terminates Tau and ASN Agreement with Voyager Signed in 2018 and 2019

AbbVie Terminates Tau and ASN Agreement with Voyager Signed in 2018 and 2019

August 5, 2020

AstraZeneca Terminates Their License Agreement with Allergan for Brazikumab Signed in 2016

AstraZeneca Terminates Their License Agreement with Allergan for Brazikumab Signed in 2016

May 11, 2020

Sierra Oncology Amends its Asset Purchase Agreement with Gilead for Momelotinib Signed in 2018

Sierra Oncology Amends its Asset Purchase Agreement with Gilead for Momelotinib Signed in 2018

November 8, 2019

AbbVie Exercises its Option to License Agreement for BioArctic's Alpha-Synuclein Antibody Portfolio- Signed in 2016

AbbVie Exercises its Option to License Agreement for BioArctic's Alpha-Synuclein Antibody Portfolio- Signed in 2016

November 2, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us